Rehabilitation Medicine Department, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
Department of Rehabilitation Medicine, Xichong County People's Hospital, Nanchong, Sichuan, People's Republic of China.
Medicine (Baltimore). 2022 Aug 19;101(33):e30002. doi: 10.1097/MD.0000000000030002.
Studies have shown that platelet-rich plasma (PRP) can enhance the effect of meniscus repair, but some studies have suggested different views on the role of PRP. Therefore, a meta-analysis was conducted to determine whether PRP can enhance the effect of meniscus repair with respect to pain reduction and improved functionality and cure rate in patients with meniscus injury.
PubMed, EMBASE, Cochrane Library Databases, clinicaltrials.gov, and the CNKI Database were searched from their inception till December 1, 2020. The RCTs reporting the outcomes of the Pain Visual Analog Scale (VAS), Lysholm score, healing rate, and adverse events were included. The risk of bias was assessed using Cochrane collaborative tools. The simulated results were expressed with effect size and 95% confidence interval, and sensitivity and subgroup analysis were performed.
The meta-analysis included 8 RCTs and 431 participants. Compared with the control group, use of PRP during meniscus surgery significantly improved the VAS (SMD: -0.40, P = .002, 95%CI: -0.66 to -0.15) and Lysholm score (MD: 3.06, P < .0001, 95%CI: 1.70-4.42) of meniscus injury, but the PRP showed no benefit in improving the healing rate of meniscus repair (RR: 1.22, P = .06, 95%CI: 0.99-1.51). No serious adverse events were reported in any study.
PRP is safe and effective in improving the effect of meniscus repair as augment. High quality RCTs with long follow-up and definitive results are needed in the future to confirm the use and efficacy of PRP in meniscus tears.
研究表明,富血小板血浆(PRP)可增强半月板修复效果,但一些研究对 PRP 的作用提出了不同的观点。因此,进行了一项荟萃分析,以确定 PRP 是否可以减轻半月板损伤患者的疼痛、改善功能和提高治愈率。
从建库至 2020 年 12 月 1 日,检索 PubMed、EMBASE、Cochrane 图书馆数据库、clinicaltrials.gov 和中国知网数据库,纳入报告疼痛视觉模拟量表(VAS)、Lysholm 评分、愈合率和不良事件结局的随机对照试验。使用 Cochrane 协作工具评估偏倚风险。模拟结果用效应大小和 95%置信区间表示,并进行敏感性和亚组分析。
荟萃分析纳入 8 项 RCT 和 431 名参与者。与对照组相比,半月板手术中使用 PRP 可显著改善 VAS(SMD:-0.40,P =.002,95%CI:-0.66 至 -0.15)和 Lysholm 评分(MD:3.06,P <.0001,95%CI:1.70-4.42),但 PRP 对改善半月板修复的愈合率无益处(RR:1.22,P =.06,95%CI:0.99-1.51)。任何研究均未报告严重不良事件。
PRP 作为半月板修复的增强剂安全有效。未来需要高质量、随访时间长、结果明确的 RCT 来证实 PRP 在半月板撕裂中的应用和疗效。